Your browser doesn't support javascript.
loading
The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer.
Butter, Rogier; Hondelink, Liesbeth M; van Elswijk, Lisette; Blaauwgeers, Johannes L G; Bloemena, Elisabeth; Britstra, Rieneke; Bulkmans, Nicole; van Gulik, Anna Lena; Monkhorst, Kim; de Rooij, Mathilda J; Slavujevic-Letic, Ivana; Smit, Vincent T H B M; Speel, Ernst-Jan M; Thunnissen, Erik; von der Thüsen, Jan H; Timens, Wim; van de Vijver, Marc J; Yick, David C Y; Zwinderman, Aeilko H; Cohen, Danielle; 't Hart, Nils A; Radonic, Teodora.
Afiliación
  • Butter R; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, The Netherlands.
  • Hondelink LM; Department of Pathology, Leiden University Medical Center, Leiden University, The Netherlands.
  • van Elswijk L; Independent Operating Psychologist, The Netherlands.
  • Blaauwgeers JLG; Department of Pathology, OLVG LAB BV, Amsterdam, The Netherlands.
  • Bloemena E; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, The Netherlands.
  • Britstra R; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, The Netherlands.
  • Bulkmans N; Department of Pathology, Spaarne Gasthuis, Haarlem, The Netherlands.
  • van Gulik AL; Department of Pathology, University Hospital Cologne, Germany.
  • Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • de Rooij MJ; Department of Pathology, Symbiant Pathology Expert Center, Alkmaar, The Netherlands.
  • Slavujevic-Letic I; Department of Pathology, Symbiant Pathology Expert Center, Alkmaar, The Netherlands.
  • Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden University, The Netherlands.
  • Speel EM; Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, University of Maastricht, The Netherlands.
  • Thunnissen E; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, The Netherlands.
  • von der Thüsen JH; Department of Pathology, Erasmus University Medical Center, Erasmus University Rotterdam, The Netherlands.
  • Timens W; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • van de Vijver MJ; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, The Netherlands.
  • Yick DCY; Department of Pathology, Amphia Hospital, Breda, The Netherlands.
  • Zwinderman AH; Department of Clinical Epidemiology and Biostatistics, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
  • Cohen D; Department of Pathology, Leiden University Medical Center, Leiden University, The Netherlands.
  • 't Hart NA; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, The Netherlands; Department of Pathology, Isala Hospitals, Zwolle, The Netherlands.
  • Radonic T; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, The Netherlands; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, The Netherlands. Electronic address: t.radonic@amste
Lung Cancer ; 166: 143-149, 2022 04.
Article en En | MEDLINE | ID: mdl-35279453
ABSTRACT

OBJECTIVES:

Programmed death-ligand 1 (PD-L1) is the only approved predictive biomarker for immunotherapy in non-small cell lung cancer (NSCLC). However, predictive PD-L1 immunohistochemistry is subject to interobserver variability. We hypothesized that a pathologist's personality influences the interobserver variability and diagnostic accuracy of PD-L1 immunoscoring. MATERIALS AND

METHODS:

Seventeen pathologists performed PD-L1 immunoscoring on 50 resected NSCLC tumors in three categories (<1%;1-49%;≥50%). Also, the pathologists completed a certified personality test (NEO-PI-r), assessing five personality traits neuroticism, extraversion, openness, altruism and conscientiousness.

RESULTS:

The overall agreement among pathologists for a series of 47 tumors was substantial (kappa = 0.63). Of these, 23/47 (49%) tumors were entirely negative or largely positive, resulting in a kappa value of 0.93. The remaining 24/47 (51%) tumors had a PD-L1 score around the cutoff value, generating a kappa value of 0.32. Pathologists with high scores for conscientiousness (careful, diligent) had the least interobserver variability (r = 0.6, p = 0.009). Also, they showed a trend towards higher sensitivity (74% vs. 68%, p = 0.4), specificity (86% vs. 82%, p = 0.3) and percent agreement (83% vs. 79%, p = 0.3), although not significant. In contrast, pathologists with high scores for neuroticism (sensitive, anxious) had significantly lower specificity (80% vs. 87%, p = 0.03) and percent agreement (78% vs. 85%, p = 0.03). Also, a trend towards high interobserver variability (r = -0.3, p = 0.2) and lower sensitivity (68% vs. 74%, p = 0.3) was observed, although not significant. Pathologists with relatively high scores for conscientiousness scored fewer tumors PD-L1 positive at the ≥ 1% cut-off (r = -0.5, p = 0.03). In contrast, pathologists with relatively high scores for neuroticism score more tumors PD-L1 positive at ≥ 1% (r = 0.6, p = 0.017) and ≥ 50% cut-offs (r = 0.6, p = 0.009).

CONCLUSIONS:

This study is the first to demonstrate the impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of immunostaining, in the context of PD-L1 in NSCLC. Larger studies are needed for validation of these findings.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos